BACKGROUND: Buprenorphine is an opioid receptor ligand whose mechanism of action is incompletely understood. METHODS: Using Ca(2+) imaging, we assessed the effects of buprenorphine, β-endorphin, and morphine on cytosolic Ca(2+) concentration [Ca(2+)](i), in rat striatal neurons. RESULTS: Buprenorphine (0.01-1 μM) increased [Ca(2+)](i) in a dose-dependent manner in a subpopulation of rat striatal neurons. The effect of buprenorphine was largely reduced by naloxone, a non-selective opioid receptor antagonist, but not by μ, κ, δ or NOP-selective antagonists. β-Endorphin (0.1 μM) increased [Ca(2+)](i) with a lower amplitude and slower time course than buprenorphine. Similar to buprenorphine, the effect of β-endorphin was markedly decreased by naloxone, but not by opioid-selective antagonists. Morphine (0.1-10 μM), did not affect [Ca(2+)](i) in striatal neurons. CONCLUSIONS: Our results suggest that buprenorphine and β-endorphin act on a distinct type/subtype of plasmalemmal opioid receptors or activate intracellular opioid-like receptor(s) in rat striatal neurons.
BACKGROUND:Buprenorphine is an opioid receptor ligand whose mechanism of action is incompletely understood. METHODS: Using Ca(2+) imaging, we assessed the effects of buprenorphine, β-endorphin, and morphine on cytosolic Ca(2+) concentration [Ca(2+)](i), in rat striatal neurons. RESULTS:Buprenorphine (0.01-1 μM) increased [Ca(2+)](i) in a dose-dependent manner in a subpopulation of rat striatal neurons. The effect of buprenorphine was largely reduced by naloxone, a non-selective opioid receptor antagonist, but not by μ, κ, δ or NOP-selective antagonists. β-Endorphin (0.1 μM) increased [Ca(2+)](i) with a lower amplitude and slower time course than buprenorphine. Similar to buprenorphine, the effect of β-endorphin was markedly decreased by naloxone, but not by opioid-selective antagonists. Morphine (0.1-10 μM), did not affect [Ca(2+)](i) in striatal neurons. CONCLUSIONS: Our results suggest that buprenorphine and β-endorphin act on a distinct type/subtype of plasmalemmal opioid receptors or activate intracellular opioid-like receptor(s) in rat striatal neurons.
Authors: L Toll; I P Berzetei-Gurske; W E Polgar; S R Brandt; I D Adapa; L Rodriguez; R W Schwartz; D Haggart; A O'Brien; A White; J M Kennedy; K Craymer; L Farrington; J S Auh Journal: NIDA Res Monogr Date: 1998-03
Authors: B N Dhawan; F Cesselin; R Raghubir; T Reisine; P B Bradley; P S Portoghese; M Hamon Journal: Pharmacol Rev Date: 1996-12 Impact factor: 25.468
Authors: Elena Deliu; Andrei A Tica; Dana Motoc; G Cristina Brailoiu; Eugen Brailoiu Journal: Am J Physiol Cell Physiol Date: 2011-05-25 Impact factor: 4.249
Authors: G Cristina Brailoiu; Elena Deliu; Andrei A Tica; Vineet C Chitravanshi; Eugen Brailoiu Journal: J Neurochem Date: 2012-08-03 Impact factor: 5.372
Authors: Elena Deliu; Margaret Sperow; Linda Console-Bram; Rhonda L Carter; Douglas G Tilley; Daniel J Kalamarides; Lynn G Kirby; G Cristina Brailoiu; Eugen Brailoiu; Khalid Benamar; Mary E Abood Journal: Mol Pharmacol Date: 2015-05-13 Impact factor: 4.436